Portfolio status

I haven't made any changes to my portfolio recently. But my personal circumstances have changed significantly. I've gone from being one half of a two-income couple / no children to the sole earner supporting a wife and baby daughter. That means I'm no longer generating spare cash each month, and I need to be more careful with cash reserves.

In January my US dollars will become available. I plan to invest these in non-sterling assets, mostly denominated in US dollars. In the meantime, I can expect a few dribs and drabs here and there, but nothing dramatic.

My reserves of cash aren't huge right now. I can afford to increase my portfolio by perhaps 20% between now and January. That's a little more than half the rate I was investing over the first half of the year.

Recent market movements
The move in the wider market have been good for my portfolio. Particular highlights over the last 3 months:

• Bond doubled. Quadnetics were up 40%, Maxima 20%.
• LLPF are up over 50% since purchase.
• RBS and Barclays continued their strong runs to be up around 40% each.

Shame my US$ fell 10%, but overall I was well in profit.

Prospective trades
At the right price:

1. Offload my Lloyds shares to eliminate the concentration of risk I have (given my large holdings of LLPF). Invest the proceeds in GSK, bringing my holding up to ~5% of my portfolio.
2. Sell my last remaining RBS shares, add some cash to the proceeds, and then bring my holdings in BAT and NG up to around 5% of my portfolio each.
3. Sell my Zirax shares and use the capital loss to reduce my taxes this year.
4. Invest further in IAPD, IDVY, IEEM, bringing each of them up to ~10% of my portfolio.

That would account for 2-3 months worth of my investment budget.

Update 24/07/09

I've executed some of my plan:

1. I've got out of my Lloyds Ordinaries at 78.5p, and invested the proceeds in GSK at 1164p. GSK is now 5.2% of my portfolio.
2. I sold out of RBS at 42.4p and invested in BATS at 1796p and NG at 566p. They are now each 5.4% of my portfolio.
3. I've decided to leave my Zirax shares alone for now. I think they are undervalued, and I can sell them anytime before the end of March 2010 and still get the benefit of the capital loss.
4. I'll leave IEEM, IAPD and IDVY for now. Depending on whether I find other opportunities worth investing in, I may wait until January before investing further.

My portfolio breakdown is now as follows:

BRK-B: 9.6% of stock/bond portfolio (excluding currency)
IEEM.L: 8.8
IAPD.L: 8.4
IDVY.L: 7.3
NXT.L: 6.8
LLPF.L: 6.4
DGE.L: 6.3
SLXX.L: 6.2
GNK.L: 5.8
NG.L: 5.4
BATS.L: 5.4
GSK.L: 5.2
TSCO.L: 5.0
BDI.L: 3.6
BARC.L: 2.7
MXM.L: 2.2
QDG.L: 2.0
CPT.L: 1.7
ZRX.L: 1.3

Here's the breakdown by asset class (including currency):
USD: 31.9% of total portfolio (including currency)
Large UK Shares: 25.6
Small UK Shares: 8.7
UK Bonds: 8.5
Large USA Shares: 6.5
Large Emerging Shares: 6.0
Large Asia Shares: 5.7
Large Europe Shares: 4.9
Small Europe Shares: 1.2
Small Emerging Shares: 0.9

So my portfolio is 42.8% in UK assets, 38.4% in US assets, 18.9% in Europe/Asia/Emerging assets. But bear in mind that a lot of my UK assets are actually international companies, e.g. GSK, BATS, DGE.